← Eichor
Study identifier: NCT05388838 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis

Condition: Uveitis · Lymphoma · NK-Cell Lymphoma  ·  Sponsor: Hospices Civils de Lyon

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Uveitis is an inflammation of the uvea, an ocular tunic comprising the iris, ciliary body and choroid. This inflammation can also involve other tissues such as the retina, the optic nerve and the aqueous humor. These diseases can result in significant vision loss and account for 10% of all blindness in developed countries, and up to 25% in developing countries. The main difficulty in this pathology is to make the etiological diagnosis, which then allows a specific treatment of the disease. The main etiologie are inflammatory or infectious (sarcoidosis, tuberculosis) but other cancerous etiologies are possible and are of more complicated diagnosis. Vitreoretinal lymphoma is a subtype of central nervous system lymphoma, which is generally associated with a poor prognosis. It is a diffuse non-Hodgkin's lymphoma, with large B cells. It can be primary ocular (Primary Intra-Ocular Lymphoma - LIOP), without brain involvement, but can also be secondary to central nervous system involvement, which explains the poor prognosis of the disease. Approximately 50-90% of LIOP develop brain involvement within 1-2 years of diagnosis, which encourages early diagnosis to avoid brain involvement as much as possible. The main obstacle to rapid diagnosis is the difficulty of identifying LIOP. Indeed, the clinical symptoms of this rare disease are often identical to classical uveitis, and the diagnostic means to detect it are invasive and require a trained ophthalmologist and hematologist team. LI…

This description comes directly from the study's public registry record.

Talk to the study team

Thibaud MATHIS, Dr  ·  4 26 10 93 22  ·  thibaud.mathis@chu-lyon.fr

Christelle SZATANEK, MsC  ·  4 26 73 27 24  ·  christelle.szatanek@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Service d'Ophtalmologie, Hôpital de la Croix-Rousse, GHNLyon, FranceRecruiting
Service d'Hématologie Clinique, Hôpital Lyon SudLyon, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05388838